API | patiromer

patiromer (veltassa) Report issue

Small molecule Approved ^FDA

AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH repoDB

Active Ingredient History

NOW

Patiromer, sold under the brand name Veltassa, is a medication used to treat high blood potassium. It is taken by mouth. It works by binding potassium in the gut. ^Wikipedia

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecules:

patiromer calcium

patiromer

More Chemistry

Pharmacology

Mechanism of Action:
Multi-specific: Missing data
Black Box: Yes
Availability: Prescription Only
Delivery Methods: Oral
Pro Drug: No

Drug Pricing (per unit)

United States

$19.2603 - $38.4288

More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Organizations (22)

Research & Development (22)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (2)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (9)

Approved Indications (1)

Hyperkalemia

Experimental Indications - Clinical Trial Phases 1-4 (9)

Chronic Kidney Disease-Mineral and Bone Disorder (Phase 3)

Diabetes Mellitus, Type 2 (Phase 4)

Drugs, Investigational (Phase 4)

Heart Failure (Phase 4)

Hyperkalemia (Phase 4)

Hypertension (Phase 2)

Kidney Failure, Chronic (Phase 4)

Kidney Transplantation (Phase 4)

Renal Insufficiency, Chronic (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 24
# of Trial Organizations: 22

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue